Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Journal of Reports in Pharmaceutical Sciences

homeHome
play_arrowCurrent IssuelistAll Issuespicture_as_pdfIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
infoJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesbar_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Publication Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
euroAPCcampaignAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Biological Evaluation and Synthesis of Benzothiazole-Piperazine Derivatives as Probable Cholinesterase Inhibitors to Treat Alzheimer’s Disease

- Hassanzadeh F. , et al.

2. Donepezil-based rational design of N-substituted quinazolinthioacetamide candidates as potential acetylcholine esterase inhibitors for the treatment of Alzheimer's disease: in vitro and in vivo studies

- Al-Karmalawy A.A. , et al.

3. Synthesis, Docking and Acetylcholinesterase Inhibitory Evaluation of 1,3,4-Thiadiazole Derivatives as Potential Anti-Alzheimer Agents

- Mohammadi-Farani A. , et al.

4. Synthesis, biological evaluation and molecular modeling studies of modulated benzyloxychalcones as potential acetylcholinesterase inhibitors

- Abdalla Ali A. , et al.

5. Synthesis, Anti-Inflammatory Activity and Molecular Docking Studies of 1,4,5,6-Tetrahydropyrimidine-2-Carboxamides

- Horishny V.Y. , et al.

6. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease

- Amin K.M. , et al.

7. Molecular docking studies of N-(((5-aryl-1,3,4-oxadiazol-2-yl)amino)methyl)-and N-(2,2,2-trichloro-1-((5-aryl-1,3,4-oxadiazol-2-yl)amino)ethyl)carboxamides as potential inhibitors of GSK-3β

- Zadorozhnii P.V. , et al.